Factors Associated with Intermittent Preventive Treatment of Malaria During Pregnancy in Mali

Intermittent preventive treatment in pregnancy (IPTp) with 3 or more doses of sulfadoxine-pyrimethamine (SP) is recommended by the World Health Organization to prevent malaria in pregnant women living in high-risk areas. According to the 2015 malaria indicator survey in Mali, malaria prevalence is 3...

Descripción completa

Detalles Bibliográficos
Autores principales: Diarra, Souleymane S., Konaté, Drissa, Diawara, Sory I., Tall, Mariam, Diakité, Mahamadou, Doumbia, Seydou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Parasitologists 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067291/
https://www.ncbi.nlm.nih.gov/pubmed/30969162
http://dx.doi.org/10.1645/17-141
_version_ 1783505381091180544
author Diarra, Souleymane S.
Konaté, Drissa
Diawara, Sory I.
Tall, Mariam
Diakité, Mahamadou
Doumbia, Seydou
author_facet Diarra, Souleymane S.
Konaté, Drissa
Diawara, Sory I.
Tall, Mariam
Diakité, Mahamadou
Doumbia, Seydou
author_sort Diarra, Souleymane S.
collection PubMed
description Intermittent preventive treatment in pregnancy (IPTp) with 3 or more doses of sulfadoxine-pyrimethamine (SP) is recommended by the World Health Organization to prevent malaria in pregnant women living in high-risk areas. According to the 2015 malaria indicator survey in Mali, malaria prevalence is 34.6%. The high risk of malaria among pregnant women and children led the Malian government to provide free SP during antenatal clinics visits. The Malian National Program of Malaria Control recommends at least 3 doses during pregnancy. The proportion of pregnant women taking 3 or more doses of IPTp-SP (IPTp 3+) still remains low. In Mali, only 36.7% of pregnant women with a live birth in the past 2 yr received IPTp 3+. To investigate the factors associated with this low coverage, we carried out a secondary data analysis using the database of the Mali 2015 Malaria Indicator Survey. Multiple logistic regression was used to analyze these factors among 2,382 interviewed women. Taking less than 3 doses was higher among women below 20 yr (adjusted odds ratio [AOR] = 1.43, 95% confidence interval [CI, 1.03; 1.98]); however, media accessibility (listening to radio) (AOR = 0.71, 95% CI [0.53–0.95]) and residing in Segou (AOR = 0.56, 95% CI [0.35–0.90]) seem to favor the opposite after adjusting the potential confusion. Residence, educational level, and wealth index were not statistically associated with taking 3 doses of IPTp-SP. This study identifies that women less than 20 yr of age were significantly associated with taking lower than 3 doses of IPTp-SP.
format Online
Article
Text
id pubmed-7067291
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher American Society of Parasitologists
record_format MEDLINE/PubMed
spelling pubmed-70672912020-03-12 Factors Associated with Intermittent Preventive Treatment of Malaria During Pregnancy in Mali Diarra, Souleymane S. Konaté, Drissa Diawara, Sory I. Tall, Mariam Diakité, Mahamadou Doumbia, Seydou J Parasitol Therapeutics-Diagnostics Intermittent preventive treatment in pregnancy (IPTp) with 3 or more doses of sulfadoxine-pyrimethamine (SP) is recommended by the World Health Organization to prevent malaria in pregnant women living in high-risk areas. According to the 2015 malaria indicator survey in Mali, malaria prevalence is 34.6%. The high risk of malaria among pregnant women and children led the Malian government to provide free SP during antenatal clinics visits. The Malian National Program of Malaria Control recommends at least 3 doses during pregnancy. The proportion of pregnant women taking 3 or more doses of IPTp-SP (IPTp 3+) still remains low. In Mali, only 36.7% of pregnant women with a live birth in the past 2 yr received IPTp 3+. To investigate the factors associated with this low coverage, we carried out a secondary data analysis using the database of the Mali 2015 Malaria Indicator Survey. Multiple logistic regression was used to analyze these factors among 2,382 interviewed women. Taking less than 3 doses was higher among women below 20 yr (adjusted odds ratio [AOR] = 1.43, 95% confidence interval [CI, 1.03; 1.98]); however, media accessibility (listening to radio) (AOR = 0.71, 95% CI [0.53–0.95]) and residing in Segou (AOR = 0.56, 95% CI [0.35–0.90]) seem to favor the opposite after adjusting the potential confusion. Residence, educational level, and wealth index were not statistically associated with taking 3 doses of IPTp-SP. This study identifies that women less than 20 yr of age were significantly associated with taking lower than 3 doses of IPTp-SP. American Society of Parasitologists 2019-04-10 2019-04 /pmc/articles/PMC7067291/ /pubmed/30969162 http://dx.doi.org/10.1645/17-141 Text en © American Society of Parasitologists 2019 http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
spellingShingle Therapeutics-Diagnostics
Diarra, Souleymane S.
Konaté, Drissa
Diawara, Sory I.
Tall, Mariam
Diakité, Mahamadou
Doumbia, Seydou
Factors Associated with Intermittent Preventive Treatment of Malaria During Pregnancy in Mali
title Factors Associated with Intermittent Preventive Treatment of Malaria During Pregnancy in Mali
title_full Factors Associated with Intermittent Preventive Treatment of Malaria During Pregnancy in Mali
title_fullStr Factors Associated with Intermittent Preventive Treatment of Malaria During Pregnancy in Mali
title_full_unstemmed Factors Associated with Intermittent Preventive Treatment of Malaria During Pregnancy in Mali
title_short Factors Associated with Intermittent Preventive Treatment of Malaria During Pregnancy in Mali
title_sort factors associated with intermittent preventive treatment of malaria during pregnancy in mali
topic Therapeutics-Diagnostics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7067291/
https://www.ncbi.nlm.nih.gov/pubmed/30969162
http://dx.doi.org/10.1645/17-141
work_keys_str_mv AT diarrasouleymanes factorsassociatedwithintermittentpreventivetreatmentofmalariaduringpregnancyinmali
AT konatedrissa factorsassociatedwithintermittentpreventivetreatmentofmalariaduringpregnancyinmali
AT diawarasoryi factorsassociatedwithintermittentpreventivetreatmentofmalariaduringpregnancyinmali
AT tallmariam factorsassociatedwithintermittentpreventivetreatmentofmalariaduringpregnancyinmali
AT diakitemahamadou factorsassociatedwithintermittentpreventivetreatmentofmalariaduringpregnancyinmali
AT doumbiaseydou factorsassociatedwithintermittentpreventivetreatmentofmalariaduringpregnancyinmali